Lisanti Capital Increases Holdings in Inspire Medical

Summary

Lisanti Capital Growth LLC has acquired new shares in Inspire Medical Systems, Inc. (NYSE: INSP), purchasing 4,810 shares valued at approximately $766,000. Other institutional investors, including Vanguard Group and Dragoneer Investment Group, have also increased their holdings in the company. Inspire Medical reported quarterly earnings per share of $0.10, exceeding expectations, with revenue growing 22.7% year-over-year. Analysts have mixed ratings on the stock, with a consensus rating of ‘Moderate Buy’ and a target price of $211.91.Market Beat

Impact Analysis

The acquisition of shares by Lisanti Capital Growth LLC highlights an increase in institutional interest in Inspire Medical Systems, indicating confidence in the company’s financial health and growth prospects. The positive earnings report, which exceeded expectations, supports this sentiment by demonstrating strong revenue growth (22.7% YoY). This event could lead to an increase in stock price as investor demand grows. The ‘Moderate Buy’ rating and target price of $211.91 suggest potential upside in the stock, presenting an opportunity for investors. Risks include the mixed analyst ratings, which may reflect uncertainties or differing opinions on future performance.Market Beat